5 Must-Know Trends in the Growing Dermatological Market

The skyrocketing cost of dermatological drugs, like Stelara and Tremfya, is pushing pharmacy budgets to the brink. With treatment prices that can soar past $160,000 per patient annually and a growing wave of diagnoses for conditions like psoriasis, healthcare decision-makers are at a breaking point. How can providers continue to afford these expensive life-changing medications without sacrificing access for patients who need them most?

The stakes have never been higher. Healthcare leaders must tackle tough questions and adopt bold, forward-thinking strategies to manage this financial strain. From maximizing the potential of biosimilars to ensuring treatments are clinically justified, the path forward requires decisive action.

Don’t fall behind – explore the five critical trends shaping these challenges and uncover proactive solutions in our latest article in Becker’s Hospital Review.

Read the full article on Becker’s now.